525 results on '"Banerjee, Sanjeev"'
Search Results
2. Therapeutic Paradigm Underscoring Glucosinolate Sulforaphane in Chemo- and Radiosensitization of Cancer: Preclinical and Clinical Perspective
3. Preclinical and Clinical Perspective on Fungal Metabolites and Their Analogs as Anticancer Agents – From Bench to Bedside
4. Data from Tumor-Initiating Cells and FZD8 Play a Major Role in Drug Resistance in Triple-Negative Breast Cancer
5. Data from A Novel Inhibitor of DNA Polymerase β Enhances the Ability of Temozolomide to Impair the Growth of Colon Cancer Cells
6. Perspective on This Article from Metformin Inhibits Cell Proliferation, Migration and Invasion by Attenuating CSC Function Mediated by Deregulating miRNAs in Pancreatic Cancer Cells
7. Data from Metformin Inhibits Cell Proliferation, Migration and Invasion by Attenuating CSC Function Mediated by Deregulating miRNAs in Pancreatic Cancer Cells
8. Supplementary Figure 1 from Tumor-Initiating Cells and FZD8 Play a Major Role in Drug Resistance in Triple-Negative Breast Cancer
9. Supplementary Data from A Novel Inhibitor of DNA Polymerase β Enhances the Ability of Temozolomide to Impair the Growth of Colon Cancer Cells
10. Pivotal Role of Chemokine Receptor Signaling Axis and Natural Bioactive Chemopreventive Agents in Metastasis of Breast Cancer
11. Polysaccharides in Cancer Prevention: From Bench to Bedside
12. Supplementary Figure 3 from TW-37, a Small-Molecule Inhibitor of Bcl-2, Inhibits Cell Growth and Induces Apoptosis in Pancreatic Cancer: Involvement of Notch-1 Signaling Pathway
13. Supplementary Figure Legends 1-3 from TW-37, a Small-Molecule Inhibitor of Bcl-2, Inhibits Cell Growth and Induces Apoptosis in Pancreatic Cancer: Involvement of Notch-1 Signaling Pathway
14. Data from 3,3′-Diindolylmethane Enhances Chemosensitivity of Multiple Chemotherapeutic Agents in Pancreatic Cancer
15. Supplementary Figure 2 from TW-37, a Small-Molecule Inhibitor of Bcl-2, Inhibits Cell Growth and Induces Apoptosis in Pancreatic Cancer: Involvement of Notch-1 Signaling Pathway
16. Supplementary Figure 1 from TW-37, a Small-Molecule Inhibitor of Bcl-2, Inhibits Cell Growth and Induces Apoptosis in Pancreatic Cancer: Involvement of Notch-1 Signaling Pathway
17. Supplementary Figure Legend from 3,3′-Diindolylmethane Enhances Chemosensitivity of Multiple Chemotherapeutic Agents in Pancreatic Cancer
18. Data from TW-37, a Small-Molecule Inhibitor of Bcl-2, Inhibits Cell Growth and Induces Apoptosis in Pancreatic Cancer: Involvement of Notch-1 Signaling Pathway
19. Supplementary Figure 1 from 3,3′-Diindolylmethane Enhances Chemosensitivity of Multiple Chemotherapeutic Agents in Pancreatic Cancer
20. The Biological Roles of MicroRNAs in Cancer Stem Cells
21. PAMAM dendrimers as promising nanocarriers for RNAi therapeutics
22. Hyaluronic acid-conjugated polyamidoamine dendrimers for targeted delivery of 3,4-difluorobenzylidene curcumin to CD44 overexpressing pancreatic cancer cells
23. Garcinol: Preclinical Perspective Underpinning Chemo- and Radiosensitization of Cancer
24. Contributors
25. Parenterally administrable nano-micelles of 3,4-difluorobenzylidene curcumin for treating pancreatic cancer
26. Cellular, Molecular, and Biological Perspective of Polyphenols in Chemoprevention and Therapeutic Adjunct in Cancer
27. Attenuation of Multifocal Cell Survival Signaling by Bioactive Phytochemicals in the Prevention and Therapy of Cancer
28. The Biology of the Deadly Love Connection Between Obesity, Diabetes, and Breast Cancer
29. Molecular Insight and Preclinical Perspective of Thymoquinone as Chemopreventive Agent and Therapeutic Adjunct in Cancer
30. The Protective Role of Zinc in Cancer: A Potential Chemopreventive Agent
31. Cellular, Molecular and Biological Insight into Chemopreventive and Therapeutic Potential of 3,3’-Diindolylmethane (DIM)
32. Deregulation of miR-146a expression in a mouse model of pancreatic cancer affecting EGFR signaling
33. The biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressiveness
34. The immunological contribution of NF-κB within the tumor microenvironment: A potential protective role of zinc as an anti-tumor agent
35. Therapeutic Paradigm Underscoring Glucosinolate Sulforaphane in Chemo- and Radiosensitization of Cancer: Preclinical and Clinical Perspective
36. Preclinical and Clinical Perspective on Fungal Metabolites and Their Analogs as Anticancer Agents – From Bench to Bedside
37. The complexities of obesity and diabetes with the development and progression of pancreatic cancer
38. Perspectives on the Role of Isoflavones in Prostate Cancer
39. Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance
40. Emerging roles of PDGF-D signaling pathway in tumor development and progression
41. Targeting Notch signaling pathway to overcome drug resistance for cancer therapy
42. Cross-talk between miRNA and Notch signaling pathways in tumor development and progression
43. Emerging role of Notch in stem cells and cancer
44. Inclusion Complex of Novel Curcumin Analogue CDF and β-Cyclodextrin (1:2) and Its Enhanced In Vivo Anticancer Activity Against Pancreatic Cancer
45. RETRACTED ARTICLE: Platelet-derived growth factor-D contributes to aggressiveness of breast cancer cells by up-regulating Notch and NF-κB signaling pathways
46. Multi-targeted therapy of cancer by genistein
47. Synergistic effects of multiple natural products in pancreatic cancer cells
48. RETRACTED ARTICLE: FoxM1 down-regulation leads to inhibition of proliferation, migration and invasion of breast cancer cells through the modulation of extra-cellular matrix degrading factors
49. FoxM1 is a Novel Target of a Natural Agent in Pancreatic Cancer
50. Structure-Activity Studies on Therapeutic Potential of Thymoquinone Analogs in Pancreatic Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.